Short-term Changes in Self-rating Depression Scale Scores after Smoking Cessation in Neurotic Patients

• Published in: Internal Medicine Vol. 60; no. 8; pp. 1175 - 1181
• Main Authors: Komiyama, Maki, Ozaki, Yuka, Miyazaki, Yusuke, Yasoda, Akihiro, Wada, Hiromichi, Yamakage, Hajime, Satoh-Asahara, Noriko, Morimoto, Tatsuya, Shimatsu, Akira, Takahashi, Yuko, Hasegawa, Koji
• Format: Journal Article
• Language: English
• Published: Japan The Japanese Society of Internal Medicine 15.04.2021; Japan Science and Technology Agency
• Subjects: Cigarette smoking; depression; Depression - epidemiology; Depressive Disorder; Drug addiction; Drug dependence; Female; Humans; Internal medicine; Mental depression; Neurosis; nicotine dependence; Original; Smoking; Smoking Cessation; Tobacco Use Disorder - therapy; nicotine dependence; depression; smoking cessation; smoking
• ISSN: 0918-2918; 1349-7235
• DOI: 10.2169/internalmedicine.4868-20

Objective The psychological status is a key factor in smoking continuance. However, details on short-term changes in mild depressive states after smoking cessation (SC) are still unknown. The purpose of the present study was to investigate these short-term changes. Methods A total of 989 patients who visited our SC Clinic were assessed using the Zung Self-Rating-Depression-Scale (SDS), an official instrument to measure depressive tendencies. The participants were classified into normal and neurotic groups based on their SDS scores during their initial visit; they were assessed again 2, 4, 8, and 12 weeks thereafter. Results The majority of patients in the neurotic group were women. These patients were also younger, with a higher nicotine dependence, and presented with a lower successful SC rate than the patients in the normal group. A decrease in SDS scores after starting the SC treatment was observed only in the neurotic group, especially during the first two weeks. In patients who continued to smoke, no improvement in depressive tendencies was noted in this period. Conclusion Depressive tendencies of patients with neurosis improve in the initial stages of the SC treatment (i.e., within two weeks after starting the treatment). This finding fills the mentioned knowledge gap regarding the effects of SC on mild depressive states in the short term.